View all news

RI Research Instruments GmbH Awarded Contract for Production of 86 Superconducting Accelerator Cavities for ARRA-Funded 12 GeV Upgrade of the DOE Thomas Jefferson National Accelerator Facility

July 09, 2009

NEWPORT NEWS, Va.--(业务线) - Bruker Advanced Supercon,Inc。的多数子公司RI研究工具今天宣布授予美国能源部(DOE)的约600万美元合同Thomas Jefferson National Accelerator Facilityin Newport News, Virginia, for the production of 86 superconducting accelerating cavities.

杰斐逊实验室合同涵盖了连续电子束加速器设施(CEBAF)的12亿级GEV(120亿元电子伏特)的所有86个超导腔,为此$65 million of ARRA fundingwas recently allocated. The 12 GeV upgrade will secure Jefferson Lab's leading global position in nuclear and particle physics research.

These superconducting cavities represent the core components of the accelerating modules that will be assembled at Jefferson Lab. The use of superconducting high purity Niobium enables the design of resonant radio-frequency accelerator cavities with extremely high quality factors (Q), operating at very high electromagnetic fields at high or 100% duty cycles. Such electromagnetic fields at high duty cycles would immediately melt normal-conducting copper cavities. Delivery is scheduled for the years 2010 and 2011.

Dr. Michael Peiniger, Managing Director of RI Research Instruments, explained: “This award fits perfectly with our advanced superconductor manufacturing, electron beam welding and surface treatment technologies. It is the continuation of a series of production contracts for accelerating cavities, such as the 360 cavities for the original installation of CEBAF, all normal conducting (48 units) and superconducting (106 units) cavities for the Spallation Neutron Source (Oak Ridge, TN), and over 100 ILC- and XFEL-type superconducting cavities for DESY (Germany), BESSY (Germany), FNAL (Batavia, IL), etc. We are committed to serving our global research customers with complete accelerator systems, as well as with series production services of sophisticated accelerator subunits.”

About RI Research Instruments and Bruker Advanced Supercon, Inc.:

RI Research Instruments GmbH is a world leader in the development and manufacturing of rf cavities and systems, linear accelerators, as well as special products for physics and energy research, scientific, medical and industrial applications. RI products include electron and ion sources, LINACs, superconducting and normal conducting accelerator cavities, other accelerator components, neutron source subunits, particle beam lines, as well as vacuum and cryogenic systems. RI Research Instruments was formed as a result of Bruker Advanced Supercon's April 1, 2009 acquisition of the research instruments business of ACCEL Instruments GmbH from Varian Medical Systems. Bruker has acquired a majority stake in RI Research Instruments and has retained Dr. Michael Peiniger as Managing Director and the former ACCEL management team as minority (45%) shareholders in the newly formed company. Bruker Advanced Supercon, Inc. of Billerica, MA has operations in the US, the UK and Germany, and is a wholly-owned subsidiary of Bruker Corporation (NASDAQ: BRKR).

For more information on RI Research Instruments, please visit:www.research-instruments.de

Photos/Multimedia Gallery Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6003808&lang=en

联系人

RI Research Instruments
Dr. Michael Peiniger, +49 2204 843676
Managing Director
michael.peiniger@research-instruments.de

类别: Press Releases
View all news